Change to the Executive Leadership Team


Werte in diesem Artikel
Aktien

58.16 EUR -2.92 EUR -4.78 %

Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025.

Werbung

Ester Baiget, President & CEO comments: "I want to thank Jacob for his strong leadership and commitment to Novonesis and our Food & Beverage Biosolutions business. Jacob has played an instrumental role in Novonesis. As a result of his contribution, the Food & Beverage Biosolutions business in Novonesis rests on a solid foundation with an extraordinary team and is uniquely positioned to drive continued growth and deliver innovative solutions to our customers. I wish Jacob all the best on his future journey.”

Jacob joined Chr. Hansen in 2006 and became a member of the Corporate Leadership Team in 2013. During his tenure in Chr. Hansen, Jacob has held multiple global sales and business unit leadership positions and since 2019 been responsible for the Food Cultures & Enzymes business unit, before entering his current role in Novonesis.

Jacob Vishof Paulsen, EVP of Food & Beverage Biosolutions continues: "I am proud of having been part of Novonesis and see amazing potential in this company. I am thankful for my time with the company and the tremendous opportunities it has provided. What I will remember the most is the people that I have worked with across the global organization.”

Werbung

The search for a replacement has been initiated and an announcement will follow in due time.


Contact information

Investor Relations               
Tobias Bjorklund                         +45 3077 8682                      tobb@novonesis.com
Anders Enevoldsen                    +45 5350 1453                       adev@novonesis.com
Katrine Spedtsberg Poulsen                                                     kats@novonesis.com

Media Relations                  
Benjamin Hjorth                          +45 3077 2731                       bht@novonesis.com

Werbung

Attachment


Aktuelle Novozymes A-S (B) Aktie News

Werbung

Novozymes A-S (B) Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novozymes A-S (B) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
17.10.12 Novozymes hold Deutsche Bank AG
03.09.12 Novozymes buy ING
28.08.12 Novozymes overweight Morgan Stanley
09.08.12 Novozymes overweight Morgan Stanley
22.06.12 Novozymes overweight Morgan Stanley

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.